The Evolution of Safe and Effective Coaguligands for Vascular Targeting and Precision Thrombosis of Solid Tumors and Vascular Malformations.

ABSTRACT: In cardiovascular and cerebrovascular biology, control of thrombosis and the coagulation cascade in ischemic stroke, myocardial infarction, and other coagulopathies is the focus of significant research around the world. Ischemic stroke remains one of the largest causes of death and disability in developed countries. Preventing thrombosis and protecting vessel patency is the primary goal. However, utilization of the body's natural coagulation cascades as an approach for targeted destruction of abnormal, disease-associated vessels and tissues has been increasing over the last 30 years. This vascular targeting approach, often termed "vascular infarction", describes the deliberate, targeted delivery of a thrombogenic effector to diseased blood vessels with the aim to induce localized activatio

SUBMITTER: Faqihi F 

PROVIDER: S-EPMC8301394 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature